新型コロナウイルス感染症用医薬品APIの世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3682)
◆英語タイトル:Global COVID-19 Drug API Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3682
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:100
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、新型コロナウイルス感染症用医薬品APIの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(ヒドロキシクロロキン、クロロキンリン酸塩、その他)、用途別市場規模(錠剤、注射)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・新型コロナウイルス感染症用医薬品APIの市場動向
・企業の競争状況、市場シェア
・新型コロナウイルス感染症用医薬品APIの種類別市場規模(ヒドロキシクロロキン、クロロキンリン酸塩、その他)
・新型コロナウイルス感染症用医薬品APIの用途別市場規模(錠剤、注射)
・新型コロナウイルス感染症用医薬品APIの北米市場規模2016-2027(アメリカ、カナダ)
・新型コロナウイルス感染症用医薬品APIの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・新型コロナウイルス感染症用医薬品APIのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・新型コロナウイルス感染症用医薬品APIの中南米市場規模2016-2027(メキシコ、ブラジル)
・新型コロナウイルス感染症用医薬品APIの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Shanghai Zhongxi Sunve Pharma Co., Ltd.、Cinkate、Fuan Pharmaceutical Group、Wuhan Wuyao Pharmaceutical Co., Ltd、Shenhua Pharmaceutical Co., Ltd、Chongqing Kangle Pharmaceutical Co., Ltd.)
・結論
【レポートの概要】

Market Analysis and Insights: Global COVID-19 Drug API Market
The global COVID-19 Drug API market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global COVID-19 Drug API market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global COVID-19 Drug API market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global COVID-19 Drug API market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global COVID-19 Drug API market.

Global COVID-19 Drug API Scope and Market Size
COVID-19 Drug API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COVID-19 Drug API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hydroxychloroquine
Chloroquine Phosphate
Others

Segment by Application
Tablet
Injection

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Shanghai Zhongxi Sunve Pharma Co., Ltd.
Cinkate
Fuan Pharmaceutical Group
Wuhan Wuyao Pharmaceutical Co., Ltd
Shenhua Pharmaceutical Co., Ltd
Chongqing Kangle Pharmaceutical Co., Ltd.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Drug API Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hydroxychloroquine
1.2.3 Chloroquine Phosphate
1.2.4 Others
1.3 Market by Application
1.3.1 Global COVID-19 Drug API Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Tablet
1.3.3 Injection
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global COVID-19 Drug API Market Perspective (2016-2027)
2.2 COVID-19 Drug API Growth Trends by Regions
2.2.1 COVID-19 Drug API Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 COVID-19 Drug API Historic Market Share by Regions (2016-2021)
2.2.3 COVID-19 Drug API Forecasted Market Size by Regions (2022-2027)
2.3 COVID-19 Drug API Industry Dynamic
2.3.1 COVID-19 Drug API Market Trends
2.3.2 COVID-19 Drug API Market Drivers
2.3.3 COVID-19 Drug API Market Challenges
2.3.4 COVID-19 Drug API Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top COVID-19 Drug API Players by Revenue
3.1.1 Global Top COVID-19 Drug API Players by Revenue (2016-2021)
3.1.2 Global COVID-19 Drug API Revenue Market Share by Players (2016-2021)
3.2 Global COVID-19 Drug API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by COVID-19 Drug API Revenue
3.4 Global COVID-19 Drug API Market Concentration Ratio
3.4.1 Global COVID-19 Drug API Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Drug API Revenue in 2020
3.5 COVID-19 Drug API Key Players Head office and Area Served
3.6 Key Players COVID-19 Drug API Product Solution and Service
3.7 Date of Enter into COVID-19 Drug API Market
3.8 Mergers & Acquisitions, Expansion Plans

4 COVID-19 Drug API Breakdown Data by Type
4.1 Global COVID-19 Drug API Historic Market Size by Type (2016-2021)
4.2 Global COVID-19 Drug API Forecasted Market Size by Type (2022-2027)

5 COVID-19 Drug API Breakdown Data by Application
5.1 Global COVID-19 Drug API Historic Market Size by Application (2016-2021)
5.2 Global COVID-19 Drug API Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America COVID-19 Drug API Market Size (2016-2027)
6.2 North America COVID-19 Drug API Market Size by Type
6.2.1 North America COVID-19 Drug API Market Size by Type (2016-2021)
6.2.2 North America COVID-19 Drug API Market Size by Type (2022-2027)
6.2.3 North America COVID-19 Drug API Market Size by Type (2016-2027)
6.3 North America COVID-19 Drug API Market Size by Application
6.3.1 North America COVID-19 Drug API Market Size by Application (2016-2021)
6.3.2 North America COVID-19 Drug API Market Size by Application (2022-2027)
6.3.3 North America COVID-19 Drug API Market Size by Application (2016-2027)
6.4 North America COVID-19 Drug API Market Size by Country
6.4.1 North America COVID-19 Drug API Market Size by Country (2016-2021)
6.4.2 North America COVID-19 Drug API Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe COVID-19 Drug API Market Size (2016-2027)
7.2 Europe COVID-19 Drug API Market Size by Type
7.2.1 Europe COVID-19 Drug API Market Size by Type (2016-2021)
7.2.2 Europe COVID-19 Drug API Market Size by Type (2022-2027)
7.2.3 Europe COVID-19 Drug API Market Size by Type (2016-2027)
7.3 Europe COVID-19 Drug API Market Size by Application
7.3.1 Europe COVID-19 Drug API Market Size by Application (2016-2021)
7.3.2 Europe COVID-19 Drug API Market Size by Application (2022-2027)
7.3.3 Europe COVID-19 Drug API Market Size by Application (2016-2027)
7.4 Europe COVID-19 Drug API Market Size by Country
7.4.1 Europe COVID-19 Drug API Market Size by Country (2016-2021)
7.4.2 Europe COVID-19 Drug API Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific COVID-19 Drug API Market Size (2016-2027)
8.2 Asia-Pacific COVID-19 Drug API Market Size by Type
8.2.1 Asia-Pacific COVID-19 Drug API Market Size by Type (2016-2021)
8.2.2 Asia-Pacific COVID-19 Drug API Market Size by Type (2022-2027)
8.2.3 Asia-Pacific COVID-19 Drug API Market Size by Type (2016-2027)
8.3 Asia-Pacific COVID-19 Drug API Market Size by Application
8.3.1 Asia-Pacific COVID-19 Drug API Market Size by Application (2016-2021)
8.3.2 Asia-Pacific COVID-19 Drug API Market Size by Application (2022-2027)
8.3.3 Asia-Pacific COVID-19 Drug API Market Size by Application (2016-2027)
8.4 Asia-Pacific COVID-19 Drug API Market Size by Region
8.4.1 Asia-Pacific COVID-19 Drug API Market Size by Region (2016-2021)
8.4.2 Asia-Pacific COVID-19 Drug API Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America COVID-19 Drug API Market Size (2016-2027)
9.2 Latin America COVID-19 Drug API Market Size by Type
9.2.1 Latin America COVID-19 Drug API Market Size by Type (2016-2021)
9.2.2 Latin America COVID-19 Drug API Market Size by Type (2022-2027)
9.2.3 Latin America COVID-19 Drug API Market Size by Type (2016-2027)
9.3 Latin America COVID-19 Drug API Market Size by Application
9.3.1 Latin America COVID-19 Drug API Market Size by Application (2016-2021)
9.3.2 Latin America COVID-19 Drug API Market Size by Application (2022-2027)
9.3.3 Latin America COVID-19 Drug API Market Size by Application (2016-2027)
9.4 Latin America COVID-19 Drug API Market Size by Country
9.4.1 Latin America COVID-19 Drug API Market Size by Country (2016-2021)
9.4.2 Latin America COVID-19 Drug API Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa COVID-19 Drug API Market Size (2016-2027)
10.2 Middle East & Africa COVID-19 Drug API Market Size by Type
10.2.1 Middle East & Africa COVID-19 Drug API Market Size by Type (2016-2021)
10.2.2 Middle East & Africa COVID-19 Drug API Market Size by Type (2022-2027)
10.2.3 Middle East & Africa COVID-19 Drug API Market Size by Type (2016-2027)
10.3 Middle East & Africa COVID-19 Drug API Market Size by Application
10.3.1 Middle East & Africa COVID-19 Drug API Market Size by Application (2016-2021)
10.3.2 Middle East & Africa COVID-19 Drug API Market Size by Application (2022-2027)
10.3.3 Middle East & Africa COVID-19 Drug API Market Size by Application (2016-2027)
10.4 Middle East & Africa COVID-19 Drug API Market Size by Country
10.4.1 Middle East & Africa COVID-19 Drug API Market Size by Country (2016-2021)
10.4.2 Middle East & Africa COVID-19 Drug API Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Shanghai Zhongxi Sunve Pharma Co., Ltd.
11.1.1 Shanghai Zhongxi Sunve Pharma Co., Ltd. Company Details
11.1.2 Shanghai Zhongxi Sunve Pharma Co., Ltd. Business Overview
11.1.3 Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Introduction
11.1.4 Shanghai Zhongxi Sunve Pharma Co., Ltd. Revenue in COVID-19 Drug API Business (2016-2021)
11.1.5 Shanghai Zhongxi Sunve Pharma Co., Ltd. Recent Development
11.2 Cinkate
11.2.1 Cinkate Company Details
11.2.2 Cinkate Business Overview
11.2.3 Cinkate COVID-19 Drug API Introduction
11.2.4 Cinkate Revenue in COVID-19 Drug API Business (2016-2021)
11.2.5 Cinkate Recent Development
11.3 Fuan Pharmaceutical Group
11.3.1 Fuan Pharmaceutical Group Company Details
11.3.2 Fuan Pharmaceutical Group Business Overview
11.3.3 Fuan Pharmaceutical Group COVID-19 Drug API Introduction
11.3.4 Fuan Pharmaceutical Group Revenue in COVID-19 Drug API Business (2016-2021)
11.3.5 Fuan Pharmaceutical Group Recent Development
11.4 Wuhan Wuyao Pharmaceutical Co., Ltd
11.4.1 Wuhan Wuyao Pharmaceutical Co., Ltd Company Details
11.4.2 Wuhan Wuyao Pharmaceutical Co., Ltd Business Overview
11.4.3 Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Introduction
11.4.4 Wuhan Wuyao Pharmaceutical Co., Ltd Revenue in COVID-19 Drug API Business (2016-2021)
11.4.5 Wuhan Wuyao Pharmaceutical Co., Ltd Recent Development
11.5 Shenhua Pharmaceutical Co., Ltd
11.5.1 Shenhua Pharmaceutical Co., Ltd Company Details
11.5.2 Shenhua Pharmaceutical Co., Ltd Business Overview
11.5.3 Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Introduction
11.5.4 Shenhua Pharmaceutical Co., Ltd Revenue in COVID-19 Drug API Business (2016-2021)
11.5.5 Shenhua Pharmaceutical Co., Ltd Recent Development
11.6 Chongqing Kangle Pharmaceutical Co., Ltd.
11.6.1 Chongqing Kangle Pharmaceutical Co., Ltd. Company Details
11.6.2 Chongqing Kangle Pharmaceutical Co., Ltd. Business Overview
11.6.3 Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Introduction
11.6.4 Chongqing Kangle Pharmaceutical Co., Ltd. Revenue in COVID-19 Drug API Business (2016-2021)
11.6.5 Chongqing Kangle Pharmaceutical Co., Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 新型コロナウイルス感染症用医薬品APIの世界市場規模・現状・予測2021年-2027年(Global COVID-19 Drug API Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。